C
C-Lab Ltd
TASE:CLAB
C-Lab Ltd
TASE:CLAB
Price:
1 151
ILS
Market Closed
Market Cap:
₪97.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
C-Lab Ltd
TASE:CLAB
|
IL |
|
V V Food & Beverage Co Ltd
SSE:600300
|
CN |
|
A
|
AQ Group AB
STO:AQ
|
SE |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
|
Andersons Inc
NASDAQ:ANDE
|
US |
|
Shenzhen Qingyi Photomask Ltd
SSE:688138
|
CN |
|
Nautilus Biotechnology Inc
NASDAQ:NAUT
|
US |
|
Supply Network Ltd
ASX:SNL
|
AU |
|
Sprouts Farmers Market Inc
NASDAQ:SFM
|
US |
|
S
|
Shenzhen Fenda Technology Co Ltd
SZSE:002681
|
CN |
|
J
|
J-Long Group Ltd
NASDAQ:JL
|
HK |
Income Statement
Earnings Waterfall
C-Lab Ltd
C-Lab Ltd
Income Statement
C-Lab Ltd
C-Lab Ltd
Currency: ILS
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
86
N/A
|
83
-3%
|
97
+16%
|
119
+24%
|
126
+6%
|
130
+3%
|
113
-13%
|
88
-23%
|
75
-15%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(56)
|
(55)
|
(65)
|
(81)
|
(85)
|
(80)
|
(68)
|
(56)
|
(55)
|
|
| Gross Profit |
30
N/A
|
29
-4%
|
31
+9%
|
38
+23%
|
41
+8%
|
50
+21%
|
45
-10%
|
32
-30%
|
20
-38%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(28)
|
(26)
|
(28)
|
(31)
|
(30)
|
(29)
|
(30)
|
(29)
|
(27)
|
|
| Selling, General & Administrative |
(12)
|
(11)
|
(13)
|
(14)
|
(15)
|
(15)
|
(15)
|
(13)
|
(12)
|
|
| Research & Development |
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(14)
|
(15)
|
(15)
|
(14)
|
|
| Depreciation & Amortization |
0
|
(1)
|
0
|
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Other Operating Expenses |
(1)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Operating Income |
2
N/A
|
2
+34%
|
3
+48%
|
8
+121%
|
11
+45%
|
21
+88%
|
16
-24%
|
3
-83%
|
(7)
N/A
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
1
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(1)
|
0
|
(1)
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
1
N/A
|
2
+102%
|
3
+74%
|
7
+139%
|
10
+54%
|
20
+97%
|
16
-23%
|
3
-79%
|
(3)
N/A
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
(1)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Income from Continuing Operations |
1
|
1
|
3
|
7
|
11
|
21
|
16
|
3
|
(3)
|
|
| Net Income (Common) |
1
N/A
|
1
+18%
|
3
+121%
|
7
+163%
|
11
+51%
|
21
+95%
|
16
-24%
|
3
-82%
|
(3)
N/A
|
|
| EPS (Diluted) |
0.12
N/A
|
0.14
+17%
|
0.32
+129%
|
0.82
+156%
|
1.24
+51%
|
2.16
+74%
|
1.83
-15%
|
0.34
-81%
|
-0.3
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
